Pharmaceutical Executive

Pharmaceutical Executive: September 2023
Volume: 43
Issue: 9

Pharmaceutical Executive: August 2023
Volume: 43
Issue: 8

Pharmaceutical Executive: July 2023
Volume: 43
Issue: 7

Pharmaceutical Executive: June 2023
Volume: 43
Issue: 6

Pharmaceutical Executive: May 2023
Volume: 43
Issue: 5

Pharmaceutical Executive: April 2023
Volume: 43
Issue: 4

Pharmaceutical Executive: March 2023
Volume: 43
Issue: 3

Pharmaceutical Executive: February 2023
Volume: 43
Issue: 02

Pharmaceutical Executive: January 2023
Volume: 43
Issue: 01

Pharmaceutical Executive-12-01-2022
Volume: 42
Issue: 12

Pharmaceutical Executive-11-01-2022
Volume: 42
Issue: 11

Pharmaceutical Executive-10-01-2022 APEX Awards Program

Pharmaceutical Executive-10-01-2022
Volume: 42
Issue: 10

Pharmaceutical Executive-09-01-2022
Volume: 42
Issue: 9

Pharmaceutical Executive-08-01-2022
Volume: 42
Issue: 8

Pharmaceutical Executive-07-01-2022
Volume: 42
Issue: 7

Pharmaceutical Executive-06-01-2022
Volume: 42
Issue: 6

Pharmaceutical Executive-05-01-2022
Volume: 42
Issue: 5

Pharmaceutical Executive-04-01-2022
Volume: 42
Issue: 4

Pharmaceutical Executive-03-01-2022
Volume: 42
Issue: 3

Pharmaceutical Executive-02-01-2022
Volume: 42
Issue: 2

Pharmaceutical Executive-01-01-2022
Volume: 42
Issue: 1

Pharmaceutical Executive-12-01-2021
Volume: 41
Issue: 12

Pharmaceutical Executive-11-01-2021
Volume: 41
Issue: 11

Pharmaceutical Executive-10-01-2021
Volume: 41
Issue: 10

Pharmaceutical Executive-09-01-2021
Volume: 41
Issue: 9

Pharmaceutical Executive-08-01-2021
Volume: 41
Issue: 8

Pharmaceutical Executive-07-01-2021
Volume: 41
Issue: 7

Pharmaceutical Executive-06-01-2021
Volume: 41
Issue: 6

Pharmaceutical Executive-05-01-2021
Volume: 41
Issue: 5
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Discloses Patient Death in CAR-T Multiple Sclerosis Trial
2
The Importance of Reframing COVID-19 as a Preventable Event
3
FDA Extends Talzenna-Xtandi to Hormone-Sensitive Prostate Cancer
4
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
5
